Angiosarcoma of the scalp responding to nivolumab: a case report

Br J Dermatol. 2018 Aug;179(2):530-531. doi: 10.1111/bjd.16698. Epub 2018 Jun 13.

Authors

S Hofer¹, K Zeidler¹, A Schipf², W Kempf^{3

4}, D Zimmermann⁵, S Aebi¹

Affiliations

¹ Division of Medical Oncology.
² Department of Pathology, Luzerner Kantonsspital, Luzern, 6000, Switzerland.
³ Pathology Kempf & Pfalz, Zürich, Switzerland.
⁴ Department of Dermatopathology.
⁵ Institute of Molecular Pathology, University Hospital Zürich, Zürich, Switzerland.

PMID: 29700818
DOI: 10.1111/bjd.16698

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Female
Head and Neck Neoplasms / drug therapy*
Head and Neck Neoplasms / pathology
Hemangiosarcoma / drug therapy*
Hemangiosarcoma / pathology
Humans
Nivolumab / therapeutic use*
Scalp / pathology*
Skin / pathology
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Treatment Outcome

Substances

Nivolumab